Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome

Abstract

The relation of pharmacokinetics of intravenous immunoglobulin (IVIg) to the outcome of Guillain-Barre syndrome (GBS) was determined in 174 adults treated at Erasmus Medical Center, Rotterdam, The Netherlands.

Keywords

• intravenous immunoglobulin
• guillain-barre syndrome
• ivig pharmacokinetics